Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates and working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Medical biomimetics industry 3600 synopsis
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 Regional trends
Chapter 3 Medical Biomimetics Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 – 2027 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Advancements in nanotechnology
3.3.1.2 Growing elderly population and increasing rate of organ failure
3.3.1.3 Growing tissue engineering market
3.3.1.4 Favorable funding scenario
3.3.2 Industry pitfalls & challenges
3.3.2.1 Stringent clinical and regulatory requirements
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By application
3.5 Porter’s analysis
3.6 Competitive landscape, 2020
3.7 PESTEL analysis
Chapter 4 Medical Biomimetics Market, By Product
4.1 Key segment trends
4.2 Cardiovascular
4.2.1 Market size by region, 2016 – 2027 (USD Million)
4.3 Orthopedic
4.3.1 Market size by region, 2016 – 2027 (USD Million)
4.3.2 Prostheses
4.3.2.1 Market size by region, 2016 – 2027 (USD Million)
4.3.3 Exoskeleton
4.3.3.1 Market size by region, 2016 – 2027 (USD Million)
4.4 Ophthalmology
4.4.1 Market size by region, 2016 – 2027 (USD Million)
4.5 Dental
4.5.1 Market size by region, 2016 – 2027 (USD Million)
4.6 Others
4.6.1 Market size by region, 2016 – 2027 (USD Million)
Chapter 5 Medical Biomimetics Market, By Application
5.1 Key segment trends
5.2 Plastic surgery
5.2.1 Market size by region, 2016 – 2027 (USD Million)
5.3 Wound Healing
5.3.1 Market size by region, 2016 – 2027 (USD Million)
5.4 Tissue engineering
5.4.1 Market size by region, 2016 – 2027 (USD Million)
5.5 Drug delivery
5.5.1 Market size by region, 2016 – 2027 (USD Million)
5.6 Others
5.6.1 Market size by region, 2016 – 2027 (USD Million)
Chapter 6 Medical Biomimetics Market, By Region
6.1 Key regional trends
6.2 North America
6.2.1 Market size by country, 2016 – 2027 (USD Million)
6.2.2 Market size by product, 2016 – 2027 (USD Million)
6.2.2.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.2.3 Market size by application, 2016 – 2027 (USD Million)
6.2.4 U.S.
6.2.4.1 Market size by product, 2016 – 2027 (USD Million)
6.2.4.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.2.4.2 Market size by application, 2016 – 2027 (USD Million)
6.2.5 Canada
6.2.5.1 Market size by product, 2016 – 2027 (USD Million)
6.2.5.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.2.5.2 Market size by application, 2016 – 2027 (USD Million)
6.3 Europe
6.3.1 Market size by country, 2016 – 2027 (USD Million)
6.3.2 Market size by product, 2016 – 2027 (USD Million)
6.3.2.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.3.3 Market size by application, 2016 – 2027 (USD Million)
6.3.4 Germany
6.3.4.1 Market size by product, 2016 – 2027 (USD Million)
6.3.4.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.3.4.2 Market size by application, 2016 – 2027 (USD Million)
6.3.5 UK
6.3.5.1 Market size by product, 2016 – 2027 (USD Million)
6.3.5.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.3.5.2 Market size by application, 2016 – 2027 (USD Million)
6.3.6 France
6.3.6.1 Market size by product, 2016 – 2027 (USD Million)
6.3.6.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.3.6.2 Market size by application, 2016 – 2027 (USD Million)
6.3.7 Spain
6.3.7.1 Market size by product, 2016 – 2027 (USD Million)
6.3.7.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.3.7.2 Market size by application, 2016 – 2027 (USD Million)
6.3.8 Italy
6.3.8.1 Market size by product, 2016 – 2027 (USD Million)
6.3.8.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.3.8.2 Market size by application, 2016 – 2027 (USD Million)
6.3.9 Russia
6.3.9.1 Market size by product, 2016 – 2027 (USD Million)
6.3.9.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.3.9.2 Market size by application, 2016 – 2027 (USD Million)
6.3.10 Poland
6.3.10.1 Market size by product, 2016 – 2027 (USD Million)
6.3.10.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.3.10.2 Market size by application, 2016 – 2027 (USD Million)
6.4 Asia Pacific
6.4.1 Market size by country, 2016 – 2027 (USD Million)
6.4.2 Market size by product, 2016 – 2027 (USD Million)
6.4.2.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.4.3 Market size by application, 2016 – 2027 (USD Million)
6.4.4 China
6.4.4.1 Market size by product, 2016 – 2027 (USD Million)
6.4.4.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.4.4.2 Market size by application, 2016 – 2027 (USD Million)
6.4.5 India
6.4.5.1 Market size by product, 2016 – 2027 (USD Million)
6.4.5.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.4.5.2 Market size by application, 2016 – 2027 (USD Million)
6.4.6 Japan
6.4.6.1 Market size by product, 2016 – 2027 (USD Million)
6.4.6.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.4.6.2 Market size by application, 2016 – 2027 (USD Million)
6.4.7 Australia
6.4.7.1 Market size by product, 2016 – 2027 (USD Million)
6.4.7.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.4.7.2 Market size by application, 2016 – 2027 (USD Million)
6.4.8 Thailand
6.4.8.1 Market size by product, 2016 – 2027 (USD Million)
6.4.8.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.4.8.2 Market size by application, 2016 – 2027 (USD Million)
6.5 Latin America
6.5.1 Market size by country, 2016 – 2027 (USD Million)
6.5.2 Market size by product, 2016 – 2027 (USD Million)
6.5.3 Market size by application, 2016 – 2027 (USD Million)
6.5.4 Market size by end-use, 2016 – 2027 (USD Million)
6.5.5 Brazil
6.5.5.1 Market size by product, 2016 – 2027 (USD Million)
6.5.5.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.5.5.2 Market size by application, 2016 – 2027 (USD Million)
6.5.6 Mexico
6.5.6.1 Market size by product, 2016 – 2027 (USD Million)
6.5.6.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.5.6.2 Market size by application, 2016 – 2027 (USD Million)
6.5.7 Argentina
6.5.7.1 Market size by product, 2016 – 2027 (USD Million)
6.5.7.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.5.7.2 Market size by application, 2016 – 2027 (USD Million)
6.6 Middle East & Africa
6.6.1 Market size by country, 2016 – 2027 (USD Million)
6.6.2 Market size by product, 2016 – 2027 (USD Million)
6.6.2.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.6.3 Market size by application, 2016 – 2027 (USD Million)
6.6.4 South Africa
6.6.4.1 Market size by product, 2016 – 2027 (USD Million)
6.6.4.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.6.4.2 Market size by application, 2016 – 2027 (USD Million)
6.6.5 Saudi Arabia
6.6.5.1 Market size by product, 2016 – 2027 (USD Million)
6.6.5.1.1 Market size, by orthopedic biomimetics, 2016 – 2027 (USD Mn)
6.6.5.2 Market size by application, 2016 – 2027 (USD Million)
Chapter 7 Company Profiles
7.1 Abbott
7.1.1 Business overview
7.1.2 Financial data
7.1.3 Product landscape
7.1.4 Strategic outlook
7.1.5 SWOT analysis
7.2 Avinent Implant System
7.2.1 Business overview
7.2.2 Financial data
7.2.3 Product landscape
7.2.4 Strategic outlook
7.2.5 SWOT analysis
7.3 Applied Biomimetics
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 Strategic outlook
7.3.5 SWOT analysis
7.4 Henry Schein
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.4.5 SWOT analysis
7.5 BioMimetic Laboratories, Inc
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 Strategic outlook
7.5.5 SWOT analysis
7.6 Chas A Blatchford & Sons Ltd (Endolite)
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.6.5 SWOT analysis
7.7 Swedish Biomimetics 3000
7.7.1 Business overview
7.7.2 Financial data
7.7.3 Product landscape
7.7.4 Strategic outlook
7.7.5 SWOT analysis
7.8 SynTouch LLC
7.8.1 Business overview
7.8.2 Financial data
7.8.3 Product landscape
7.8.4 Strategic outlook
7.8.5 SWOT analysis
7.9 Otsuka Holdings Co , Ltd (Veryan Medical)
7.9.1 Business overview
7.9.2 Financial data
7.9.3 Product landscape
7.9.4 Strategic outlook
7.9.5 SWOT analysis
7.10 Wright Medical Group N.V.
7.10.1 Business overview
7.10.2 Financial data
7.10.3 Product landscape
7.10.4 Strategic outlook
7.10.5 SWOT analysis
